Continuing Education
2025 Therapeutic Updates
Best Suited For: Pharmacist, Pharmacy Technician
CE Credits: 1 hours
Course Description
The goal of this activity is to provide pharmacists, pharmacy technicians, and nurses a with a comprehensive overview of newly FDA-approved therapies in 2025. The session will review new oncology drugs, including mechanism of action, safety, dosing and administration instructions. Participants will gain knowledge and understanding of these newly approved therapies and their place in clinical practice.
Learning Objectives
- Review FDA approved indications of some oncology drugs from 2025
- Explain the mechanism of action of new oncology drug classes approved in 2025
- Summarize clinical trial data that led to the new oncology drug approvals in 2025
- Describe safety & monitoring of the new oncology drugs approved in 2025
- Discuss the place in therapy of the new 2025 oncology drug approvals with current therapies
Fees
This activity does not require payment to register.
To receive credit you must participate and complete all the steps found in the “Complete Credit Requirements” link provided by the registration confirmation email. After following the link, these steps will include:
- Reviewing the course learning materials.
- Confirming information provided on registration.
- Claiming participation in applicable credits.
- Completing all listed evaluations and quizzes.
Credit requirements must be completed before the expiration date of the activity. Upon completion, credit will be transmitted electronically to the ACPE. All transmitted credit will be viewable in your CPE Monitor profile within 24 hours.
Login to Register for this Course
Register for the course and access course materials by logging into our learning management system.